Nxera Pharma Co., Ltd. (TYO:4565)
1,363.00
+20.00 (1.49%)
Oct 26, 2026, 3:30 PM JST
Nxera Pharma Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Nxera Pharma stock has a consensus rating of "Buy" and an average price target of ¥1,828. The average 1-year stock price forecast is 34.08% higher than the current stock price, while the lowest is ¥1,000 (-26.63%) and the highest is ¥3,000 (+120.10%).
Price Target: ¥1,828 (+34.08%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Nxera Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Financial Forecast
Revenue This Year
37.81B
from 29.62B
Increased by 27.66%
Revenue Next Year
41.99B
from 37.81B
Increased by 11.06%
EPS This Year
62.39
from -138.80
EPS Next Year
39.33
from 62.39
Decreased by -36.96%
Financial currency is JPY.